[Form 4] Arts-Way Manufacturing Co Inc Insider Trading Activity

Rhea-AI Filing Summary

Thomas E. Buffamante, a director of Arts-Way Manufacturing Co., acquired 1,000 shares of common stock on 08/31/2025 as fully-vested restricted stock under the company's director compensation plan. The transaction shows a $0 price for the grant and increases his beneficial ownership to 58,000 shares, reported as direct ownership. The Form 4 was filed by a single reporting person and signed by an attorney-in-fact on the same date. The filing does not disclose derivative transactions, amendments, or additional cash consideration.

Positive

• Director received fully-vested restricted stock under the director compensation plan, indicating immediate ownership rather than contingent awards.
• Beneficial ownership increased to 58,000 shares, with the change reported as direct ownership.
• Form 4 appears complete for the disclosed non-derivative transaction, including reporting person, relationship, transaction date, and signature.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: A director received fully-vested restricted shares, modestly increasing direct ownership to 58,000 shares; routine director compensation disclosure.

This Form 4 documents a standard director-compensation equity grant rather than an open-market purchase or option exercise. Fully-vested restricted stock issued at $0 typically reflects compensation for board service rather than a cash-based investment. From a governance perspective, the disclosure is timely and complete for the specific non-derivative transaction reported, but it provides no information about vesting contingencies beyond the statement that the shares are fully vested.

Securities Compliance Analyst

TL;DR: Filing properly reports the director's grant and resultant beneficial ownership; no flagged irregularities in the disclosed items.

The form identifies the reporting person, relationship to the issuer (director), transaction date, and the signature by an attorney-in-fact, satisfying key Form 4 elements. There are no derivative positions disclosed and the report indicates a direct ownership change. The grant was reported with a $0 price, consistent with equity awards made as compensation. The filing contains no indications of amendments, Rule 10b5-1 plans, or unusual transaction codes that would raise compliance concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Buffamante Thomas E

(Last) (First) (Middle)

5556 HIGHWAY 9

(Street)

ARMSTRONG IA 50514

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARTS WAY MANUFACTURING CO INC [ ARTW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/31/2025		A		1,000(1)	A	$0	58,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents fully-vested restricted stock granted pursuant to the director compensation plan.

	/s/ Michael W. Woods as Attorney-in-Fact for Thomas E. Buffamante	08/31/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Thomas E. Buffamante report on Form 4 for ARTW?

He reported the acquisition of 1,000 shares of common stock on 08/31/2025 as fully-vested restricted stock.

How many ARTW shares does the reporting person own after the transaction?

The Form 4 states he beneficially owns 58,000 shares following the reported transaction.

Was any cash paid for the shares reported on the Form 4?

The transaction is reported with a $0 price, indicating the shares were granted as compensation.

Is the reported ownership direct or indirect for the ARTW transaction?

The filing indicates direct (D) ownership for the 58,000 shares after the transaction.

Who signed the Form 4 for Thomas E. Buffamante?

The Form 4 was signed by Michael W. Woods as Attorney-in-Fact for Thomas E. Buffamante on 08/31/2025.